$RGDXQ Asset Value: $0.361 per share. Response develops, manufactures and markets rapid onsite diagnostic tests for use with its RAMP platform for clinical, biodefense and environmental applications.
RAMP represents a unique paradigm in diagnostics that provides reliable, quality results in minutes.
The RAMP platform consists of a reader and single use disposable test cartridges and has the potential to be adapted to any other medical and nonmedical immunoassay based test currently performed in laboratories.
Response clinical tests are commercially available for the aid in early detection of heart attack, congestive heart failure, thromboembolism and infectious diseases.
In the nonclinical market, RAMP tests are currently available for the environmental detection of West Nile Virus antigen and for Biodefense applications including the rapid onsite detection of anthrax, smallpox, ricin and botulinum toxin.
Latest News JUN 1, 2020 Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates https://www.cancergenetics.com/
Business Description;
We are a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer (theranosis).
Our proprietary tests target cancers where prognosis information is critical and where predicting treatment outcomes using currently available techniques is limited.
These cancers include ematological, urogenital and HPV-associated cancers.
We have commercially launched MatBA -CLL and -SLL, our first proprietary microarray diagnostic tests, and seek to provide our tests and services to oncologists and pathologists at hospitals, cancer centers and physician offices, as well as to biopharmaceutical companies and clinical research organizations for their clinical trials.
will "signal" moves in advance buy using small amounts of buys or sells as "signals".
The "signals" are such a small amount of shares (worth no more than 5 or 10 dollars) that no trader would have paid a commission that costs more than the amount of shares bought.
The "signals" are from one MM to another.
100 - I need shares.
200 - I need shares badly, but do not take the stock down.
300 - Take the price down so I can load shares
400 - Keep trading it sideways.
500 - Gap the stock.
This gap can be either up or down, depending on the direction of the 500 signal. ====================================================== 505 - I am short on shares 600 - Means provide resistance 900 - Means let the stock float 911 - Pending News/Press Release On The Way 1000 - Don't let it run 2100 - Let it run
ADDING; List Of Market Maker Signals 1. 100 - I need Shares. 2. 200 - I need Shares badly but do not take the stock down. 3. 300 - Take (or I am taking) the stock down at least 30% so I can load shares. 4. 400 - Keep trading it sideways. 5. 500 - Gap the stock. Gap can be up or down, depending on direction of 500 signal.
6. 505 - I am short on shares 7. 600 - Apply resistance at the ASK to keep the price from increasing. 8. 700 - Move the price up. 9. 777 - Also recognized as a signal to move the price up. 10. 800 - Prepare for an increase in trading volume.
11. 900 - Allow the stock to float and trade freely. 12. 911 - Pending News/Press Release On The Way 13. 1000 - Don't let it run 14. 2100 - Let it run
News 
Market Data 
Discover 
